PreprintCited by 254Congenital heart defects researchDevelopmental Biology and Gene RegulationPluripotent Stem Cells Research

Embryonic Heart Progenitors and Cardiogenesis

Open access
Brade, T., Pane, L. S., Moretti, A., Chien, K. R., Laugwitz, K.-L.·2013·Cold Spring Harbor Perspectives in Medicine

Abstract

The mammalian heart is a highly specialized organ, comprised of many different cell types arising from distinct embryonic progenitor populations during cardiogenesis. Three precursor populations have been identified to contribute to different myocytic and nonmyocytic cell lineages of the heart: cardiogenic mesoderm cells (CMC), the proepicardium (PE), and cardiac neural crest cells (CNCCs). This review will focus on molecular cues necessary for proper induction, expansion, and lineage-specific differentiation of these progenitor populations during cardiac development in vivo. Moreover, we will briefly discuss how the knowledge gained on embryonic heart progenitor biology can be used to develop novel therapeutic strategies for the management of congenital heart disease as well as for improvement of cardiac function in ischemic heart disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a013847

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. Ã Chien K. 2013. Pluripotent stem cell technology and regen- erative cardiovascular medicine. Cold Spring Harb Per- spect Med doi: 10.1101/cshperspect.a013870. · DOI
  2. Ã Mummery C. 2013. Paradigms for heart cell therapeutics. Cold Spring Harb Perspect Med doi: 10.1101/cshper- spect.a013862. · DOI

Cited by

Sorted by citations

Authors
Brade, T., Pane, L. S., Moretti, A., Chien, K. R., & Laugwitz, K.-L.
Affiliations
  • TUM Klinikum (DE)
  • Harvard University (US)
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2013-10-01
Volume
3
Issue
10
Pages
a013847-a013847
ISSN
2157-1422 (ISSN-L)
OpenAlex
W2170437462
Cited by
254
References
110
Citations by year
2026: 11 · 2025: 15 · 2024: 27 · 2023: 23 · 2022: 23 · 2021: 24 · 2020: 26 · 2019: 18 · 2018: 19 · 2017: 20 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 2
Type
posted content
Language
en
Open access
Locations
  • Cold Spring Harbor Perspectives in Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • Deutsches Zentrum für Herz-Kreislaufforschung
  • Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
heart development, proepicardium, cardiac neural crest cells, lineage-specific differentiation, congenital heart disease, ischemic heart disease, cardiac regeneration
MeSH terms
Animals, Cell Differentiation, Heart, Heart Defects, Congenital, Humans, Mesoderm, Myocardium, Neural Crest, Pericardium, Neovascularization, Physiologic, Cell Lineage, Regenerative Medicine, Embryonic Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review